Trucept (TREP) AI Stock Analysis

• Market Cap: $1.78M
• Dividend Yield: N/A
• Average Volume (3M): 8.52K
• Price to Earnings (P/E): 1.6
• Beta (1Y): 0.53
• Revenue Growth: 12.52%
• EPS Growth: -121.51%
• Country: US
• Employees: 28
• Sector: Industrials
• Sector Strength: 72
• Industry: Staffing & Employment Services
• EPS (TTM): -0.02
• Shares Outstanding: 52,762,123
• 10 Day Avg. Volume: 6,368
• 30 Day Avg. Volume: 8,515
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 1.03
• Enterprise Value/Revenue: 0.08
• Enterprise Value/Gross Profit: 0.12
• Enterprise Value/Ebitda: 1.04
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 67 Neutral
• Price Target: ―

Trucept shows strong financial performance with significant revenue growth and improving profitability, supported by a stable balance sheet and enhanced cash flow management. However, the technical analysis presents mixed signals, and the low P/E ratio indicates it might be undervalued. The absence of earnings call data and corporate events does not affect the score calculation.

Positive Factors

Revenue Growth

Strong revenue growth indicates robust demand for Trucept's services, enhancing its market position and supporting long-term business expansion.

Profitability Improvement

Improving profitability reflects better cost management and operational efficiency, contributing to sustainable financial health and competitiveness.

Low Leverage

Low leverage reduces financial risk, providing Trucept with greater flexibility to invest in growth opportunities and withstand economic downturns.

Negative Factors

Decreased Return on Equity

A decrease in return on equity suggests potential inefficiencies in generating returns on shareholders' equity, which could impact investor confidence and capital allocation.

Cash Generation Concerns

Insufficient cash generation from operations relative to net income may limit Trucept's ability to fund growth initiatives and meet financial obligations.

EBIT Margin Pressure

Decreasing EBIT margin indicates rising operational costs, which could erode profitability if not managed effectively, impacting long-term financial performance.

Trucept Business Overview & Revenue Model

Company Description

True solutions, today and tomorrow: Trucept Inc. helps organizations focus on growing their business. With a dedicated suite of powerful tools and services designed to put business owners in charge of running their businesses and increasing efficiency, Trucept tackles a variety of important administrative needs and provides a host of value-added advantages. For more information, call 858-798-1620 or visit https://truceptservices.com/.

How the Company Makes Money

Trucept makes money by offering a variety of business services that are critical to the operational success of its clients. Its revenue model is based on service fees charged to companies for payroll processing, human resource management, and employee benefits administration. Trucept also earns money from consulting services, helping clients improve efficiency and compliance within their operations. Key revenue streams include recurring fees for ongoing services, such as payroll and benefits administration, as well as one-time fees for consulting projects. Additionally, Trucept may have partnerships with other service providers or software companies to enhance their offerings, though specific partnerships are not detailed.

Trucept Financial Statement Overview

Summary

Trucept demonstrates strong revenue growth and improving profitability, with a consistent gross profit margin and significant revenue increase. The balance sheet indicates low leverage and financial risk but shows a decrease in the return on equity. Cash flow analysis reveals improved cash flow management, but there is still a need for better cash generation from operations.

Income Statement

Trucept demonstrates strong revenue growth and improving profitability. The gross profit margin improved consistently, reaching 64.5% in 2024. Net profit margin also improved from 8.5% in 2023 to 5.7% in 2024. Revenue grew by 25.5% year-over-year from 2023 to 2024, indicating robust sales performance. However, the EBIT margin has decreased slightly, showing potential pressure on operating costs.

Balance Sheet

The balance sheet shows a stable equity position with an equity ratio of 18.9% in 2024, compared to 47.9% in 2023. The debt-to-equity ratio remains low at 0.1, indicating low leverage and financial risk. However, the return on equity has decreased to 86.7% in 2024 from 7.5% in 2023, reflecting potential inefficiencies in generating returns on shareholders' equity.

Cash Flow

Cash flow analysis reveals improvement, with positive operating cash flow in 2024. Free cash flow showed substantial growth from negative in 2023 to positive in 2024. However, the operating cash flow to net income ratio is below 1, indicating a need to improve cash generation from operations relative to net income.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	22.99M	18.32M	20.11M	17.58M	12.29M
Gross Profit	14.83M	12.21M	13.75M	9.31M	6.53M
EBITDA	1.76M	1.56M	3.71M	1.81M	-157.73K
Net Income	1.31M	1.56M	1.52M	1.65M	1.08M
Balance Sheet
Total Assets	7.98M	43.20M	25.94M	31.37M	29.95M
Cash, Cash Equivalents and Short-Term Investments	3.12M	2.29M	123.00K	67.86K	33.47K
Total Debt	155.66K	0.00	0.00	3.70M	4.01M
Total Liabilities	6.47M	22.49M	6.94M	14.31M	14.53M
Stockholders Equity	1.51M	20.71M	19.00M	17.06M	15.41M
Cash Flow
Free Cash Flow	819.76K	-13.54M	1.98M	2.41M	4.65M
Operating Cash Flow	829.16K	-13.53M	2.01M	2.44M	4.65M
Investing Cash Flow	-1.87K	-644.79K	-31.65K	-27.98K	-158.30K
Financing Cash Flow	0.00	16.35M	-1.92M	-2.38M	-4.46M

Trucept Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.03
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TREP, the sentiment is Negative. The current price of 0.03 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.04, and below the 200-day MA of 0.04, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 43.20 is Neutral, neither overbought nor oversold. The STOCH value of -44.44 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TREP.

Trucept Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TREP	67 Neutral	$1.78M	1.60	-3.01%	―	12.52%	-121.51%
Sector *	64 Neutral	$10.84B	15.28	7.40%	1.99%	2.87%	-14.59%
DHX	57 Neutral	$142.59M	268.89	-8.83%	―	-8.31%	-445.30%
STRR	56 Neutral	$34.61M	―	-9.37%	―	42.94%	50.97%
BGSF	49 Neutral	$71.75M	―	-9.13%	4.69%	-24.36%	-393.95%
JOB	48 Neutral	$20.92M	―	-53.10%	―	-15.53%	-67.84%
IPDN	43 Neutral	$7.87M	―	-68.25%	―	-11.76%	48.03%